Compass Pathways Plc (CMPS)
13.06
+1.14
(+9.56%)
USD |
NASDAQ |
May 29, 16:00
12.97
-0.09
(-0.69%)
After-Hours: 20:00
Compass Pathways Enterprise Value : 1.349B for May 29, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Silence Therapeutics Plc | 80.26M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -17.80M |
| Mereo BioPharma Group Plc | 18.47M |
| Definium Therapeutics, Inc. | 2.306B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 77.50M |
| Total Expenses (Quarterly) | -77.50M |
| EPS Diluted (Quarterly) | -0.3044 |
| Earnings Yield | -24.18% |
| Normalized Earnings Yield | -21.57 |